PI
ONC

PineBridge Investments’s BeOne Medicines Ltd ONC Stock Holding History

PineBridge Investments’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-101
Closed -$16K – 759
2022
Q2 		$16K Buy
+101
New +$15.8K ﹤0.01% 686
2022
Q1 		– Sell
-100
Closed -$27K – 839
2021
Q4 		$27K Buy
+100
New +$33.8K ﹤0.01% 757

Other funds holding ONC

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CII
Capital International Inc Los Angeles, California $13B AUM 31.88% 1-Year Est. Return

PineBridge Investments's ONC Position: Q3 2022 in Review

PineBridge Investments sold out of BeOne Medicines Ltd (ONC) in Q3 2022, closing a stake of 101 shares — an estimated $16K sold.

PineBridge Investments first reported a position in ONC in Q4 2021 and held it in 2 quarters. The position peaked at $27K in Q4 2021. 222 funds tracked by Wall St. Rank hold ONC as of Q3 2022.

  • PineBridge Investments reported no remaining BeOne Medicines Ltd position as of Q3 2022 after selling out during the quarter.
  • PineBridge Investments sold 101 BeOne Medicines Ltd shares in Q3 2022, an estimated $16K.
  • PineBridge Investments first reported a position in BeOne Medicines Ltd in Q4 2021 and held it in 2 quarters.
  • PineBridge Investments's BeOne Medicines Ltd position peaked at $27K in Q4 2021.
  • 222 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q3 2022.

Based on PineBridge Investments's 13F filing for Q3 2022, filed 10 Nov 2022.